SCHEMBL3359911

SCHEMBL3359911

CCC1CC(=O)C=C2CC[C@@H]3[C@H](CC[C@]4(CC)[C@H](C)CC[C@@H]34)[C@H]21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 9/20 0.38
▸ SHBG P04278 2/20 0.35
▸ SERPINA6 P08185 2/20 0.35
▸ SLC22A1 O15245 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ THRB P10828 1/20 0.35
▸ AR P10275 9/20 0.35
▸ LMNA P02545 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ SLC6A4 P31645 2/20 0.35
▸ NR3C1 P04150 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ ABCB11 O95342 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ CYP19A1 P11511 2/20 0.35
▸ NR3C2 P08235 3/20 0.35
▸ MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3643602 0.87 SHBG (0.35) PGRSHBGSERPINA6SLC22A1ALDH1A1
SCHEMBL13770501 0.79 CYP19A1 (0.57) PGRSHBGSERPINA6SLC22A1ALDH1A1
SCHEMBL13474780 0.79 CYP19A1 (0.57) PGRSHBGSERPINA6SLC22A1ALDH1A1
SCHEMBL3358546 0.79 PGR (0.40) PGRSHBGSERPINA6SLC22A1ALDH1A1
SCHEMBL8209833 0.78 CYP19A1 (0.59) SHBGSERPINA6ALDH1A1LMNACYP19A1
SCHEMBL5077118 0.78 SHBG (0.40) PGRSHBGSERPINA6SLC22A1ALDH1A1
SCHEMBL5552057 0.78 SHBG (0.61) PGRSHBGSERPINA6SLC22A1ALDH1A1
SCHEMBL7705294 0.78 SHBG (0.61) PGRSHBGSERPINA6SLC22A1ALDH1A1
SCHEMBL29496903 0.78 SHBG (0.61) PGRSHBGSERPINA6SLC22A1ALDH1A1
SCHEMBL11517324 0.77 SHBG (0.46) PGRSHBGSERPINA6SLC22A1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010066354-A1 USE OF 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-ENE DERIVATIVES FOR MANUFACTURING A MEDICAMENT IN A SUSTAINED-RELEASE FORM FOR PARENTERAL USE, AND SUSTAINED-RELEASE MEDICAMENT CONTAINING 17β-CYANO-18A-HOMO-19-NOR-ANDROST-4-ENE DERIVATIVES FOR PARENTERAL USE BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-06-17 — — WO disclosed
Send feedback